Surgery Partners, Inc.
SGRY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,114,300 | $2,743,300 | $2,539,300 | $2,225,100 |
| % Growth | 13.5% | 8% | 14.1% | – |
| Cost of Goods Sold | $2,368,700 | $2,095,800 | $1,964,400 | $1,733,700 |
| Gross Profit | $745,600 | $647,500 | $574,900 | $491,400 |
| % Margin | 23.9% | 23.6% | 22.6% | 22.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $138,700 | $120,900 | $102,200 | $104,000 |
| SG&A Expenses | $138,700 | $120,900 | $102,200 | $104,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $258,100 | $198,600 | $127,500 | $85,200 |
| Operating Expenses | $396,800 | $319,500 | $229,700 | $189,200 |
| Operating Income | $348,800 | $328,000 | $345,200 | $302,200 |
| % Margin | 11.2% | 12% | 13.6% | 13.6% |
| Other Income/Exp. Net | -$201,700 | -$193,000 | -$234,900 | -$221,000 |
| Pre-Tax Income | $147,100 | $135,000 | $110,300 | $81,200 |
| Tax Expense | $134,600 | -$300 | $23,300 | $10,500 |
| Net Income | -$168,100 | -$11,900 | -$54,600 | -$70,900 |
| % Margin | -5.4% | -0.4% | -2.2% | -3.2% |
| EPS | -1.33 | -0.095 | -0.59 | -1.12 |
| % Growth | -1,304.4% | 83.9% | 47.3% | – |
| EPS Diluted | -1.33 | -0.095 | -0.59 | -1.12 |
| Weighted Avg Shares Out | 126,122 | 125,613 | 91,952 | 72,427 |
| Weighted Avg Shares Out Dil | 126,122 | 125,613 | 91,952 | 72,427 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $201,700 | $193,000 | $234,900 | $221,000 |
| Depreciation & Amortization | $152,600 | $118,100 | $114,800 | $98,800 |
| EBITDA | $501,400 | $446,100 | $460,000 | $401,000 |
| % Margin | 16.1% | 16.3% | 18.1% | 18% |